Beryl Drugs Profit & Loss Annual

Trade
BSE: 524606 | NSE: - | ISIN: INE415H01017 | Sector: Biotechnology & Drugs
33.10 +0.57 (1.75%)Updated : 26 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 26.7326.8914.6014.09
Total Revenue 26.7326.8914.6014.09
Costof Revenue Total 13.1514.548.407.42
Gross Profit 13.5812.356.206.67
Selling/ General/ Admin Expenses Total 1.931.701.311.18
Depreciation/ Amortization 1.200.801.071.25
Other Operating Expenses Total 9.388.714.484.05
Total Operating Expense 25.6525.7615.2813.92
Operating Income 1.081.13-0.680.17
Interest Inc( Exp) Net- Non- Op Total -4.64-4.16-3.970.25
Other Net 0.400.270.120.15
Net Income Before Taxes 1.010.98-0.950.35
Provisionfor Income Taxes 0.240.22-0.290.11
Net Income After Taxes 0.770.77-0.660.24
Net Income Before Extra Items 0.770.77-0.660.24
Net Income 0.770.77-0.660.24
Income Availableto Com Excl Extra Ord 0.770.77-0.660.24
Income Availableto Com Incl Extra Ord 0.770.77-0.660.24
Diluted Net Income 0.770.77-0.660.24
Diluted Weighted Average Shares 0.510.510.510.51
Diluted EPS Excluding Extra Ord Items 1.521.51-1.300.47
Diluted Normalized EPS 1.521.51-1.300.47
Interest Exp( Inc) Net- Operating Total -0.130.160.20
Total Adjustmentsto Net Income -0.00--
Dilution Adjustment -0.00--
*All figures in crores except per share values
Recommended For You
Trending Stocks
6,758.65+72.15(1.08%)
1,801.25+16.65(0.93%)
1,593.65+14.15(0.90%)
HomeMarketsPremiumInstant LoanMint Shorts